Today: 22 December 2025
Subscribe
Browse Category

NYSE:TMO News 31 July 2025 - 19 December 2025

Thermo Fisher Scientific Stock (TMO) After Hours: Key News, Analyst Forecasts, and What to Watch Before the Market Opens on Dec. 19, 2025

Thermo Fisher Scientific Stock (TMO) After Hours: Key News, Analyst Forecasts, and What to Watch Before the Market Opens on Dec. 19, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) finished Thursday’s session (December 18, 2025) essentially flat and is showing little urgency in post-market trading—setting up a “watch the catalysts” kind of setup heading into Friday’s open (December 19, 2025). The stock closed
19 December 2025
 ·  ·  ·  ·  · 
Thermo Fisher Scientific (TMO) Stock Today: Alzheimer’s Registry Launch, Analyst Price Targets, and 2026 Catalysts (Dec. 18, 2025)

Thermo Fisher Scientific (TMO) Stock Today: Alzheimer’s Registry Launch, Analyst Price Targets, and 2026 Catalysts (Dec. 18, 2025)

WALTHAM, Mass. / Markets — December 18, 2025: Thermo Fisher Scientific Inc. (NYSE: TMO) is in focus Thursday as investors weigh a new Alzheimer’s real‑world evidence initiative from its PPD CorEvitas clinical registries business alongside a steady stream of Wall
18 December 2025
 ·  ·  ·  ·  · 
Thermo Fisher Scientific (TMO) Stock: Fresh Deals, Wall Street Upgrades and Long‑Term Outlook as of December 4, 2025

Thermo Fisher Scientific (TMO) Stock: Fresh Deals, Wall Street Upgrades and Long‑Term Outlook as of December 4, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) is ending 2025 with strong momentum. The life‑science giant’s shares are trading around $570–$575 today, after a powerful rebound from mid‑year lows and a series of bullish analyst upgrades, strategic acquisitions and new partnerships.
4 December 2025
 ·  ·  ·  ·  · 
Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts

Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts

Thermo Fisher Scientific Inc. (NYSE: TMO), one of the world’s largest life sciences and diagnostics companies, is closing out 2025 with a flurry of news that matters for shareholders: a fresh analyst upgrade, new insider transactions, big institutional flows, a
1 December 2025
 ·  ·  ·  ·  · 
Thermo Fisher Scientific (TMO) Stock News Today: Insider Selling, Institutional Buying and New Growth Moves – November 28, 2025

Thermo Fisher Scientific (TMO) Stock News Today: Insider Selling, Institutional Buying and New Growth Moves – November 28, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) stayed in the spotlight on November 28, 2025, with a cluster of headlines ranging from insider selling and fresh institutional stakes to new product launches and operational updates that could shape the stock’s medium‑term
29 November 2025
 ·  ·  ·  ·  · 
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Overview Index Performance The 1 October 2025 session began under a cloud as the federal government shut down due to a budget impasse. Stock futures opened lower amid fears that key economic reports might be delayed investopedia.com. By the closing bell,
1 October 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Biotech & Health Bombshells: FDA Greenlights, Clinical Breakthroughs & Global Health Milestones (Aug 8–9, 2025)

Biotech & Health Bombshells: FDA Greenlights, Clinical Breakthroughs & Global Health Milestones (Aug 8–9, 2025)

Drug Approvals & Regulatory Developments (In Europe, regulators also made news: the EMA’s committee recommended approving darolutamide (Bayer’s Nubeqa) with hormone therapy for metastatic prostate cancer based on positive Phase 3 data onclive.com.) Clinical Trials & Research Breakthroughs Public Health
9 August 2025
 ·  ·  ·  ·  ·  · 
Go toTop